What is NDC 60219-2283?

60219-2283 is the product NDC for Deflazacort, Deflazacort 18 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals NY LLC, NDC labeler code 60219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Deflazacort?

31 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Deflazacort NDC 60219-2283 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60219-2283Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60219-2283Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60219-2283-1	6021922830160219228301	1 BOTTLE in 1 CARTON (60219-2283-1) / 30 TABLET in 1 BOTTLEMarketed from Dec 12, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Deflazacort
Generic name (nonproprietary): deflazacort
Active ingredients: Deflazacort — 18 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLCNDC labeler code 60219
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217173
Marketing start: Dec 12, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 60219-2283_bf2296a0-7eb0-484f-b054-3d405c2c1dcaSPL ID bf2296a0-7eb0-484f-b054-3d405c2c1dcaSPL set ID 18518568-a40b-41cb-91ce-44fbb5557971RxCUI 153098, 153880, 1870954, 1870958UNII KR5YZ6AE4BUPC 0360219228313, 0360219228511, 0360219228412, 0360219228214
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460219228301 followed by a unit qualifier and the quantity

Package 60219-2283-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 16, 2025.

Indications (excerpt from the label)

Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) tablets. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60219-2283

What is NDC 60219-2283?: 60219-2283 is the product NDC for Deflazacort, Deflazacort 18 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Deflazacort.
What is the active ingredient?: Deflazacort.
Who is the labeler?: Amneal Pharmaceuticals NY LLC, NDC labeler code 60219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Deflazacort?: 31 other product NDCs are listed under this name. See all Deflazacort NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Deflazacort NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Deflazacort	Deflazacort 6 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0824	00054-0824-25
Deflazacort	Deflazacort 18 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0825	00054-0825-13
Deflazacort	Deflazacort 30 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0826	00054-0826-13
Deflazacort	Deflazacort 36 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0827	00054-0827-13
Deflazacort	Deflazacort 6 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2282	60219-2282-01
Deflazacort	Deflazacort 30 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2284	60219-2284-01
Deflazacort	Deflazacort 36 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2285	60219-2285-01
Deflazacort	Deflazacort 6 mg/1	TabletOral	AvKARE	73190-068	73190-0068-01
Deflazacort	Deflazacort 18 mg/1	TabletOral	AvKARE	73190-069	73190-0069-30
Deflazacort	Deflazacort 30 mg/1	TabletOral	AvKARE	73190-070	73190-0070-30

All 32 Deflazacort NDCs

Other NDCs under ANDA 217173

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217173
Product	Strength	Form · route	Labeler	Product NDC
Deflazacort	Deflazacort 6 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2282
Deflazacort	Deflazacort 30 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2284
Deflazacort	Deflazacort 36 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2285